000-001-GP9
ERK1 C-Term Blocking Peptide
Eine Lieferung in diese Region ist nicht möglich.
- SKU:
- 000-001-GP9
- Zusätzliche Namen:
- MAPK3|MAPK3, ERK, ERK1, PRKM3, ERK-1 Blocking peptide, ERK-1 Control peptide
- Anwendung:
- WB
- Konzentration:
- 1 mg/ml
- Physischer Zustand:
- Lyophilized
- Reinheit:
- >95%
- Lagerbedingungen:
- Please refer to datasheet
- Hersteller:
- Rockland Inc
- Immunogen:
- MAPK3
- Spezies:
- Human
- Uniprot:
- P27361
- Synonyme:
- ERK-1;ERK1;ERT2;extracellular signal-regulated kinase 1;extracellular signal-related kinase 1;HS44KDAP;HUMKER1A;insulin-stimulated MAP2 kinase;MAP kinase isoform p44;MAPK 1;microtubule-associated protein 2 kinase;mitogen-activated protein kinase 3;p44-ERK1;p44-MAPK;P44ERK1;P44MAPK;PRKM3
- Weitere Details:
- Mitogen activated protein kinase 3, also known as MAPK3, ERK, or ERK1, is an integral component of the MAP kinase cascade that regulates cell growth and differentiation. ERK1 and ERK2 are activated by MEK1 and MEK2 in the B-raf signaling pathway resulting in its translocation to the nucleus where it phosphorylates nuclear targets. Human ERK1 and ERK2 are 84% identical in sequence and share common functionality in cells. ERK1 is ideal for investigators involved in Neuroscience, Cell Signaling and Cancer Research.
- Versandbedingungen:
- Ambient